Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Hypo-osmolar ORS
Total 0 results
Nothing found
Sponsors and Collaborators
OLVG, Amsterdam, the Netherlands
Virginia G. Kaklamani
Bruno Rhiner
E. Steve Woodle
Camilla Wistrand
BiondVax Pharmaceuticals ltd.
Eyal Ashkenazi
STAG1 Gene Foundation
Department of Emergency Medicine, The First People's Hospital of Hangzhou, Hangzhou, China.
Vituity Psychiatry
Medical College Trivandrum
Ministère de la Santé et l'Hygiène Publique, Mali
AtheroNova Inc.
Katarzyna Jórasz
MITO
Yu-Hsiang Wu
Nottingham University Hospitals NHS Trust
Asahi Kasei Medical Co., Ltd.
LM Farma Indústria e Comércio Ltda.
GenVivo, Inc.
View Full List
Medical Conditions
Soft Tissue Sarcoma, Adult, Stage II
Child Physical Activity
Phenoxymethylpenicillin
Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
Synbiotics
Serum Bank
Intensive Care Neuropathy
Nondepolarising Muscle Relaxants
Stage IVA Lymphoepithelioma of the Oropharynx
Rotator Cuff Lesion
Learning Disturbance
HPV-Related Anal Intraepithelial Neoplasia
NR3C2
Imaging, Diagnostic
Cervical Cancer Stage IA2
Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
Symptoms
Any Injury or Illness Acutely Impacting Work
Autism or Autistic Traits
Mast-Cell Sarcoma
View Full List
Drug Interventions
Rituximab plus CHOP
Interleukin-2
Ozanimod
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
CD25 treatment
LDEPA
5-Fluorouracil
Interferon beta-1b (Betaferon, BAY86-5046)
Insulin
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
FHND5071
Lidocaine/ ketamine
Apremilast
Dexmedetomidine
Methotrexate
Thiotepa
Exendin 9-39
Miglustat
Extended release guanfacine
Transdermal estradiol
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Costa Rica
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Georgia
Contract Research Organizations in Greece
Contract Research Organizations in Guatemala
Contract Research Organizations in Japan
Contract Research Organizations in Mauritania
Contract Research Organizations in Myanmar
Contract Research Organizations in Panama
Contract Research Organizations in Philippines
Contract Research Organizations in Romania
CRO list by country
CROs in Cambodia
Lucerent
SGS
All CROs in Cambodia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe